Terminated PHASE3 INTERVENTIONAL 3-arm NCT00559351

RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus

Possibilities for Improvement of an Outcome of the Treatment in Squamous Cell Carcinoma of the Thoracic Esophagus - a Multicenter Randomized Clinical Phase III Trial.

Sponsor: Ministry of Scientific Research and Information Technology, Poland

Conditions Esophageal Neoplasms Squamous Cell Cancer

Interventions neoadjuvant chemoradiotherapy neoadjuvant chemotherapy (cisplatin, 5-fluorouracil) transthoracic esophagectomy 2-field extended lymphadenectomy

Updated 4 times since 2017 Last updated: Nov 15, 2007 Started: Dec 31, 2001 Completion: Apr 30, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

difficulty in recruitment

Other Esophageal Neoplasms trials with similar outcome

Browse all Esophageal Neoplasms trials

A PHASE3 clinical study on Esophageal Neoplasms and Squamous Cell Cancer, this trial is terminated or withdrawn. The trial is conducted by Ministry of Scientific Research and Information Technology, Poland and has accumulated 4 data snapshots since 2001. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jan 2017 — Jan 2021 [monthly]

Terminated PHASE3

First recorded

Dec 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ministry of Scientific Research and Information Technology, Poland

Data source: Ministry of Scientific Research and Information Technology, Poland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lublin, Poland